Cargando…
Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells
Chronic Myeloid Leukemia is a neoplastic disease characterized by the abnormal expansion of hematopoietic cells with compromised functions. Leukemic cells often display a multidrug resistance phenotype, enabling them to evade a number of structurally unrelated cytotoxic compounds. One of those mecha...
Autores principales: | Oliveira, Thaís, Lemos, Douglas, Jean, Louise, Kawashima, Jéssica M., de Azevedo, Vitória R., Salustiano, Eduardo J., Rumjanek, Vivian M., Monteiro, Robson Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204307/ https://www.ncbi.nlm.nih.gov/pubmed/35719932 http://dx.doi.org/10.3389/fonc.2022.852985 |
Ejemplares similares
-
Metabolic Reprogramming During Multidrug Resistance in Leukemias
por: Vidal, Raphael Silveira, et al.
Publicado: (2018) -
Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias
por: Vidal, Raphael Silveira, et al.
Publicado: (2018) -
Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels
por: Chiara, Federica, et al.
Publicado: (2008) -
Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
por: Rumjanek, Vivian M., et al.
Publicado: (2013) -
Hexokinases inhibit death receptor–dependent apoptosis on the mitochondria
por: Lauterwasser, Joachim, et al.
Publicado: (2021)